Q BioMed Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 11.33M and sold 129.2K QBIO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 11.33M shares
Sell 129.2K shares
72% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
May 26, 2022
Buy
Common Stock
A-Award
Corin Denis
Chief Executive Officer
CEO / President 200 000
Value: $4.00B
May 26, 2022
Buy
Common Stock
A-Award
Corin Denis
Chief Executive Officer
CEO / President 200 000
Value: $4.00B
Feb 01, 2021
Buy
Common stock
A-Award
Rosenstadt William S
Chief Legal Officer
Officer 35 000
Value: $0
Feb 01, 2021
Buy
Common stock
A-Award
Rosenstadt William S
Chief Legal Officer
Officer 35 000
Value: $0
Oct 27, 2020
Buy
Incentive Stock Options
A-Award
Corin Denis
Chief Executive Officer
CEO / President 500 000
Value: $515.0K
Oct 27, 2020
Buy
Incentive Stock Options
A-Award
Rosenstadt William S
Chief Legal Officer
Officer 500 000
Value: $515.0K
Oct 27, 2020
Buy
Incentive Stock Options
A-Award
Rosenstadt William S
Chief Legal Officer
Officer 500 000
Value: $515.0K
Oct 27, 2020
Buy
Incentive Stock Options
A-Award
Corin Denis
Chief Executive Officer
CEO / President 500 000
Value: $515.0K
Aug 29, 2020
Buy
Incentive Stock Options
A-Award
Corin Denis
Chief Executive Officer
CEO / President 150 000
Value: $225.0K
Aug 29, 2020
Buy
Incentive Stock Options
A-Award
Corin Denis
Chief Executive Officer
CEO / President 150 000
Value: $225.0K
Aug 29, 2020
Buy
Incentive Stock Options
A-Award
Rosenstadt William S
Chief Legal Officer
Officer 150 000
Value: $225.0K
Aug 29, 2020
Buy
Incentive Stock Options
A-Award
Rosenstadt William S
Chief Legal Officer
Officer 150 000
Value: $225.0K
Aug 29, 2020
Buy
Incentive Stock Options
A-Award
Rosenstadt William S
Chief Legal Officer
Officer 150 000
Value: $225.0K
Aug 29, 2020
Buy
Incentive Stock Options
A-Award
Rosenstadt William S
Chief Legal Officer
Officer 150 000
Value: $225.0K
Aug 29, 2020
Buy
Incentive Stock Options
A-Award
Corin Denis
Chief Executive Officer
CEO / President 150 000
Value: $225.0K
Aug 29, 2020
Buy
Incentive Stock Options
A-Award
Corin Denis
Chief Executive Officer
CEO / President 150 000
Value: $225.0K
Apr 06, 2020
Buy
Incentive Stock Options
A-Award
Rosenstadt William S
Chief Legal Officer
Officer 225 000
Value: $477.0K
Apr 06, 2020
Buy
Incentive Stock Options
A-Award
Rosenstadt William S
Chief Legal Officer
Officer 225 000
Value: $477.0K
Feb 10, 2020
Buy
Incentive Stock Options
A-Award
Corin Denis
Chief Executive Officer
CEO / President 750 000
Value: $0
Feb 10, 2020
Buy
Incentive Stock Options
A-Award
Corin Denis
Chief Executive Officer
CEO / President 750 000
Value: $1.59M
Feb 10, 2020
Buy
Incentive Stock Options
A-Award
Rosenstadt William S
Chief Legal Officer
Officer 750 000
Value: $1.59M
Feb 10, 2020
Buy
Incentive Stock Options
A-Award
Rosenstadt William S
Chief Legal Officer
Officer 750 000
Value: $1.59M
Feb 10, 2020
Buy
Incentive Stock Options
A-Award
Corin Denis
Chief Executive Officer
CEO / President 750 000
Value: $1.59M
Feb 10, 2020
Buy
Incentive Stock Options
A-Award
Corin Denis
Chief Executive Officer
CEO / President 750 000
Value: $0
Dec 05, 2019
Buy
Incentive StockOptions
A-Award
Panicucci Rick
Director
Director 150 000
Value: $225.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT Q BIOMED INC.
Q BioMed
Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain. It is also developing Man-01, a pre-clinical lead candidate for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-v...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE